Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Why Indegene’s BioPharm acquisition could become the blueprint for AI-first commercialization models in pharma Discover how Indegene’s $104 million acquisition of BioPharm is setting a new paradigm in AI-driven precision pharma marketing. byVenkateshOctober 8, 2025